NBP NovaBridge Biosciences
$1.59▼ -5.92%
Healthcare
Other
After hours
$1.59▲ +0.00%
Sep 11, 7:51 PM ET
Volume 252.8K
Avg Volume (10D) 219.2K
Key Metrics & Fundamentals
Market Cap
$183.88M
P/E Ratio
–
Div Yield
–%
52W Range
1.46 - 6.79
% vs 50 MA
-12.39%
% vs 200 MA
-39.88%
RSI-14
34.1
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$14.60M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$70.95M
COGS
–
Operating Exp
$72.90M
Operating Income
-$72.90M
EBIT
-$72.90M
Pretax Income
-$72.86M
Net Income
-$30.79M
Price & Volume History
Loading chart…
Recent News
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
GlobeNewswire · Sep 8, 2026 11:00 AM
NovaBridge Biosciences to Participate in September Investor Conferences
GlobeNewswire · Aug 27, 2026 11:00 AM
NovaBridge Biosciences (NBP) (H1 2026) Earnings Call Highlights: Strong Cash Position and ...
GuruFocus.com · Aug 20, 2026 9:02 PM
NovaBridge Biosciences Q2 2026 Earnings Call Summary
Moby · Aug 20, 2026 12:30 PM
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
GlobeNewswire · Aug 20, 2026 11:00 AM
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
GlobeNewswire · Aug 13, 2026 9:00 PM
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
GlobeNewswire · Jul 24, 2026 9:00 PM
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
GlobeNewswire · Jun 29, 2026 11:00 AM
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer
GlobeNewswire · Jun 16, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NBP's money flow as a full page
Social Sentiment
No Reddit posts found for NBP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.